Is racecadotril (antisecretory agent) 100 mg three times a day (tds) for 5 days a safe dose to reduce stool episodes in non-bacterial diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Racecadotril 100 mg TDS for Non-Bacterial Diarrhea

Racecadotril 100 mg three times daily for 5 days is generally safe and effective for reducing stool episodes in adults with non-bacterial diarrhea, with fewer side effects than antimotility agents like loperamide. 1

Mechanism and Efficacy

Racecadotril is an enkephalinase inhibitor with antisecretory properties that:

  • Reduces intestinal hypersecretion of water and electrolytes 2
  • Does not affect intestinal motility (unlike loperamide) 1, 2
  • Works by inhibiting neutral endopeptidase (NEP), allowing enkephalins to exert their antisecretory effects 3

Safety Profile

Advantages over Loperamide

  • Produces significantly less constipation (16% vs 25% with loperamide) 1
  • Causes fewer adverse events overall (14.2% vs 23.9% with loperamide) 1
  • Provides more rapid resolution of abdominal symptoms 1
  • Does not prolong intestinal transit time 2
  • Does not promote bacterial overgrowth in the small intestine 2

Side Effects

  • Generally mild and transient 4
  • No serious adverse events directly attributed to racecadotril have been reported 3
  • No potential for neurotoxicity or physical dependence 2

Dosing Considerations

The recommended dosing of 100 mg three times daily for adults is appropriate and consistent with clinical studies 1. This dosage has been shown to be as effective as loperamide for resolving diarrhea (average resolution time of 55 hours) while causing fewer side effects 1.

Clinical Guidance

When to Use

  • For acute watery non-bacterial diarrhea in adults 5
  • As an adjunct to oral rehydration therapy 4
  • When antimotility agents like loperamide are contraindicated or poorly tolerated 6

When to Avoid

  • In cases of bloody diarrhea (dysentery) 5
  • In suspected bacterial infections requiring antibiotic treatment 5
  • In severe diarrhea with moderate to severe cramping, fever, or dehydration 6

Monitoring and Expected Outcomes

  • Clinical improvement should be observed within 48 hours of initiating treatment 6
  • If symptoms persist beyond this timeframe, reevaluation of the underlying cause is warranted 6
  • The 5-day treatment course is appropriate for most cases of acute non-bacterial diarrhea 1

Comparison to Alternative Treatments

While the Infectious Diseases Society of America notes that racecadotril is not available in North America 5, it is widely used in many other countries as an effective alternative to loperamide 6. Clinical studies have demonstrated that racecadotril:

  • Is as effective as loperamide in resolving diarrhea 1
  • Has a better side effect profile than loperamide 1
  • Does not cause the rebound constipation commonly seen with antimotility agents 1, 2

Conclusion

Racecadotril 100 mg three times daily for 5 days is a safe and effective treatment for reducing stool episodes in non-bacterial diarrhea. Its favorable safety profile makes it a good option for patients who cannot tolerate or have contraindications to antimotility agents like loperamide.

References

Research

Racecadotril: a new approach to the treatment of diarrhoea.

International journal of antimicrobial agents, 2000

Research

Drugs in Focus: The Use of Racecadotril in Paediatric Gastrointestinal Disease.

Journal of pediatric gastroenterology and nutrition, 2020

Research

Racecadotril in the treatment of acute watery diarrhea in children.

The New England journal of medicine, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diarrhea Management in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.